Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing. - sprookjes - yvandenbroek - TriplyDB

Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.

Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.

http://www.wikidata.org/entity/Q35234108

about

The genetics of uveal melanoma: current insights The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy.The diagnostic application of RNA sequencing in patients with thyroid cancer: an analysis of 851 variants and 133 fusions in 524 genes Shifting patterns of genomic variation in the somatic evolution of papillary thyroid carcinoma.Identification of insertions in PTEN and TP53 in anaplastic thyroid carcinoma with angiogenic brain metastasis.Mitochondrial Metabolism as a Treatment Target in Anaplastic Thyroid Cancer.SF3B1 and EIF1AX mutations occur in primary leptomeningeal melanocytic neoplasms; yet another similarity to uveal melanomas.Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.Anaplastic Thyroid Carcinoma, Version 2.2015.Mutational burdens and evolutionary ages of thyroid follicular adenoma are comparable to those of follicular carcinoma.The biology of uveal melanoma miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.Cell Cycle M-Phase Genes Are Highly Upregulated in Anaplastic Thyroid Carcinoma.Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.Single-cell approaches for molecular classification of endocrine tumors.Thyroid cancer in 2015: Molecular landscape of thyroid cancer continues to be deciphered.Expression of angiogenic switch, cachexia and inflammation factors at the crossroad in undifferentiated thyroid carcinoma with BRAF(V600E).Genomic Landscape of poorly Differentiated and Anaplastic Thyroid Carcinoma.Candidate microRNAs as biomarkers of thyroid carcinoma: a systematic review, meta-analysis, and experimental validation.A Concise Atlas of Thyroid Cancer Next-Generation Sequencing Panel ThyroSeq v.2.Primary Thyroid Carcinoma with Low-Risk Histology and Distant Metastases: Clinicopathologic and Molecular Characteristics.Real-Time Genomic Characterization Utilizing Circulating Cell-Free DNA in Patients with Anaplastic Thyroid Carcinoma.Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer.Eukaryotic translation initiation factors and cancer.Prevalence and phenotypic correlations of EIF1AX mutations in thyroid nodules.Absence of somatic mutations of the mTOR gene in differentiated thyroid cancer.NGS based identification of mutational hotspots for targeted therapy in anaplastic thyroid carcinoma Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer.Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance.Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: identification of TERT mutation as an independent risk factor for transformation.Follicular cell-derived thyroid cancer.Refractory thyroid carcinoma: which systemic treatment to use?Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancer.Genetic and epigenetic characterization of low-grade gliomas reveals frequent methylation of the MLH3 gene.Genetic analysis of 779 advanced differentiated and anaplastic thyroid cancers.Transposon mutagenesis identifies chromatin modifiers cooperating with Ras in thyroid tumorigenesis and detects ATXN7 as a cancer gene.Expression of serum AMPD1 in thyroid carcinoma and its clinical significance.Genomic Heterogeneity and Exceptional Response to Dual Pathway Inhibition in Anaplastic Thyroid Cancer.EIF1AX Mutation in a Patient with Hürthle Cell Carcinoma.

P2860

Q28073150-8A8A51D9-188F-4AD2-8C64-A13B8928FFCD Q35872419-8E6F5452-5078-42D0-940B-8ED65C48CC90 Q35906347-CDEE54DB-6E5B-440D-8933-B38C0DF521C1 Q36107501-97719DEF-8393-429D-A502-C925B29BD846 Q36171837-301D1CF4-7E7C-4BAA-9BC5-30D55E6E0F47 Q36328030-63D07827-F727-40F1-BFC3-D9F32ED22413 Q36466870-44E291FC-8F0A-4E4C-8518-527FC3E704E3 Q36618604-C843A287-2C9C-4680-8AAB-6EB735BF5C33 Q37179204-E5698DDE-07E3-49A7-8BFF-22A58CF81337 Q37688417-88B18C19-8B7B-4123-8DA9-C992BEA577C4 Q37742632-17A69EB7-FAA8-4EA1-8BF2-9B523F2E43A9 Q38395979-21F49DEE-885E-4130-BD1E-40B649908697 Q38441002-D186CA67-4296-49E9-8D08-ADA0731F1C67 Q38614394-AAAE6788-EF66-483F-9796-C3E6EA133966 Q38657760-177635AA-ADB8-41E5-B14E-D9D8E01A9BA3 Q38657773-47850110-EA93-4F31-8B34-F4EE00B8DC9F Q38669515-BEC47AEC-6E6D-43A7-AFE1-A483E07CA23B Q38851509-31D4C425-9C5D-414E-8868-7BD2DA89B615 Q38884271-776F20D8-9129-4247-8D31-ED87D5268C64 Q38910482-8AF3C54E-86A4-449D-8146-6CB400E7EBD1 Q39002421-F1909B67-0FB0-4BE5-8B2E-CC058DCE3BA5 Q39066104-F59993A0-DFA6-4077-B19B-60D6ED30B2BC Q39244943-CE1C5FBA-5528-47A0-A42F-C32DC707F403 Q39328851-30A9214F-450A-4751-AACE-09B56CC6718D Q39400409-3B860087-AAE1-4EA2-B9D8-90B0B1F0C917 Q40979072-422D032E-B29E-4FA0-A50B-7710284F3CD5 Q41602327-DD0B65E0-450D-4CE2-8C43-0CA60ECF327E Q42014310-8B9DEF8E-7B4B-4474-B074-0437513D95B6 Q46636066-7B639CB5-9797-44BE-9A01-5D83DA34056F Q47295202-53A3B4D6-274D-495D-8833-965C381A10A5 Q48088782-36F3089E-7098-4CDF-9163-EC57B9FB4341 Q48651339-11DE55A1-B77A-4427-A17C-FDF2FACB185B Q49335901-3261F5CA-1DA9-4E79-AC3C-3BD03AF5CECB Q49569565-781135E0-8640-4206-8B65-E0B17A9ED650 Q52150633-1E073552-209F-493F-B817-6B352803EB55 Q52609129-02A8D35F-FD84-484C-BB16-D0BE5294B319 Q52621195-5ED0AE37-9431-41BB-ACCE-51449330AEF6 Q52653065-3612167D-A7B3-4EDA-A7DD-BEB520209CC0 Q52839686-86D8890E-C3DA-437A-8007-DD891711DD23 Q53051365-0CB929AD-6CAA-4B8D-B358-EFD2AE95BA0B

P2860

Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.

http://www.wikidata.org/entity/Q35234108

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Characterization of the mutati ...... er via whole-exome sequencing.

@ast

Characterization of the mutati ...... er via whole-exome sequencing.

@en

type

label

Characterization of the mutati ...... er via whole-exome sequencing.

@ast

Characterization of the mutati ...... er via whole-exome sequencing.

@en

prefLabel

Characterization of the mutati ...... er via whole-exome sequencing.

@ast

Characterization of the mutati ...... er via whole-exome sequencing.

@en

P1433

Q35234108-11402ED2-2A5F-4715-BB48-EEEE6610F789

P1476

Q35234108-EB6B9DFA-CB08-4437-AF40-B6EAE84C2BFC

P2093

Q35234108-1C0DA178-60EA-458C-94F0-B479BA07E17A

Q35234108-1E49D11F-C2DF-4B6D-B15D-BCE77A0FADD0

Q35234108-3783087D-C3C7-4C0D-AE82-6FD43547F330

Q35234108-6936A7F1-A55A-4FEC-B420-7ED7BA87C065

Q35234108-7EF12878-FBBE-4E9F-BFD9-E7A2828C2998

Q35234108-ABF80217-59D0-4BA4-9411-F4BB657F46A2

Q35234108-B1FA3B34-A84B-4B90-A9D7-8FBC4AECF6BA

Q35234108-B4E6B31F-8CC7-42F7-A083-1477CED4DFEB

Q35234108-B7F217DE-AAE6-4F77-BD2E-A5595F99A6C8

Q35234108-C852CDDC-D565-48C4-900D-465F7EEC1AE3

P2860

Q35234108-063DA023-8017-40B5-948E-209878C364D9

Q35234108-10B8DB41-E135-43C9-BE1C-3338C7BEF856

Q35234108-11A95DC4-6F85-4DF4-87DC-6CDEBD2E7AE2

Q35234108-14EFB206-4C55-4277-975B-0363B80E6548

Q35234108-1A50E20A-AA34-4332-BFB7-AB33FB0F1DD5

Q35234108-1AE3BBEE-11DA-4BFA-876F-09C8ECAD7CC4

Q35234108-1C895CB1-DC88-4097-93C4-02DF88D80354

Q35234108-1E69C32F-FDD6-4B0B-A03A-7412819E46BC

Q35234108-212CB6B5-5FCA-4F34-969B-84E304295495

Q35234108-22FD0398-2660-495B-8873-B52F14C232EB

P304

Q35234108-3C0121C6-1C72-44D2-8ECC-936AD270F573

P31

Q35234108-8D7827A1-68F0-45B2-BEE9-0D8BB7F28BE3

P356

Q35234108-D00B2CC9-B7CF-4325-9D1A-5FAFB9EF361D

P433

Q35234108-A6A66487-F80F-48D8-9C40-02676A06E576

P478

Q35234108-F8C85375-E257-43A0-B8F1-01AD6A4D72AC

P50

Q35234108-37A75429-074F-429A-8057-B698BAE91F5E

Q35234108-B95E827D-6C9B-4C9A-BCC0-B6D38BFB44EB

Q35234108-D2D80B6F-206A-4257-A757-D2E5BEF7A3F7

Q35234108-F93F24FE-F5ED-44C0-BCF2-45E6E4281A68

Q35234108-FAB4F078-64D3-4D51-B7D0-201098EB340D

P577

Q35234108-B7B9CCBC-76D6-4F52-A8F5-B05B9C4AD901

P698

Q35234108-D4DBBE70-E5E6-47CB-9293-A9FA6AA0951F

P932

Q35234108-8D53521D-0087-46A0-98FD-54597F941200

P356

P1433

Human Molecular Genetics

P1476

Characterization of the mutati ...... er via whole-exome sequencing.

@en

P2093

Anders Höög

http://www.w3.org/2001/XMLSchema#string

Carol Nelson-Williams

http://www.w3.org/2001/XMLSchema#string

Catharina Larsson

http://www.w3.org/2001/XMLSchema#string

David L Rimm

http://www.w3.org/2001/XMLSchema#string

Jan Zedenius

http://www.w3.org/2001/XMLSchema#string

Jill C Rubinstein

http://www.w3.org/2001/XMLSchema#string

Manju L Prasad

http://www.w3.org/2001/XMLSchema#string

Murim Choi

http://www.w3.org/2001/XMLSchema#string

Nimrod Kiss

http://www.w3.org/2001/XMLSchema#string

Reju Korah

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic diagnosis by whole exome capture and massively parallel DNA sequencing

Cancer genome landscapes

Whole-exome sequencing identifies recessive WDR62 mutations in severe brain malformations

Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma

Recent developments in prognostic and predictive testing in uveal melanoma

Methods, challenges, and promise of next-generation sequencing in cancer biology

Response and acquired resistance to everolimus in anaplastic thyroid cancer

The ErbB/HER family of protein-tyrosine kinases and cancer

Identification of a recurrent STRN/ALK fusion in thyroid carcinomas

Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3

P304

2318-2329

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HMG/DDU749

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

John W Kunstman

P577

2015-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25576899

http://www.w3.org/2001/XMLSchema#string

P932

4380073

http://www.w3.org/2001/XMLSchema#string